Cellular MSI-H Score: a Robust Predictive Biomarker for Immunotherapy Response and Survival in Gastrointestinal Cancer

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2024 Dec 11

PMID 39659917

Authors

Feilong Zhao

Shu Wang

Yuezong Bai

Jinping Cai

Yuhao Wang

Yuxuan Ma

Haoyuan Wang

Yan Zhao

Juan Wang

Cheng Zhang

Jing Gao

Jianjun Yang

Affiliations

Soon will be listed here.

Abstract

Microsatellite instability-high (MSI-H) is a critical biomarker for immunotherapy, yet primary resistance remains a significant challenge. Current MSI-H detection methods evaluate the proportion of MSI-H loci, termed molecular MSI-H score, which can be affected by intratumoral heterogeneity (ITH). To address this limitation, we propose evaluating MSI-H at the cellular level to improve the prediction of immunotherapy outcomes. Using bulk tissue (TCGA-CRC) and cell line (CCLE-CRC) datasets, we identified genes highly expressed in MSI-H and MSS samples. These signatures were applied to a single-cell RNA sequencing (scCRC) dataset for enrichment analysis, enabling classification of tumor cells into MSI-H, MSS, and microsatellite dual (MSD) clusters using a Gaussian finite mixture model. Validation showed that MSI-H and MSS enrichment scores were higher in mismatch repair-deficient (MMRd) and mismatch repair-proficient (MMRp) patients, respectively. Functional enrichment analysis revealed that MSI-H cells were associated with pathways such as carboxylic acid catabolism, inflammatory responses, and IL-6/JAK2/STAT3 signaling. We developed a cellular MSI-H signature using genes specifically expressed in the MSI-H cell cluster and transformed the scCRC dataset into a cell-type-specific pseudobulk expression matrix. Using this matrix as a reference, we performed reference-based deconvolution on TCGA-CRC data. We defined the deconvolution score of MSI-H cell as cellular MSI-H score. This score strongly correlated with the molecular MSI-H score (R = 0.55, P < 0.001) and showed modest correlations with macrophage (MoMac, R = 0.14) and CD8+ T-cell (R = 0.11). To investigate its potential for clinical application, we applied the cellular MSI-H signature to the BJ-cohort, comprising 97 immunotherapy-treated gastrointestinal patients sequenced with a 395-gene panel. The cellular MSI-H score was significantly higher in responders (P = 0.002), positively correlated with tumor reduction percentage (R = 0.29, P = 0.006), and associated with improved progression-free survival (PFS) (HR: 0.00, 95% CI: 0.00-0.31, P = 0.021). In summary, the cellular MSI-H score reflects the MSI-H cell level within a tumor and demonstrates superior accuracy compared to molecular MSI-H status in predicting immunotherapy response and PFS. This underscores its potential as a more robust biomarker for guiding immunotherapy decisions.

References

Andre T, Shiu K, Kim T, Jensen B, Jensen L, Punt C . Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. N Engl J Med. 2020; 383(23):2207-2218. DOI: 10.1056/NEJMoa2017699. View

Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L . Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther. 2023; 8(1):9. PMC: 9816309. DOI: 10.1038/s41392-022-01270-x. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

Hartwig A, Schwerdtle T . Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications. Toxicol Lett. 2002; 127(1-3):47-54. DOI: 10.1016/s0378-4274(01)00482-9. View

Hartwig A, Asmuss M, Blessing H, Hoffmann S, JAHNKE G, Khandelwal S . Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic stability. Food Chem Toxicol. 2002; 40(8):1179-84. DOI: 10.1016/s0278-6915(02)00043-1. View

Ren X, Kang B, Zhang Z . Understanding tumor ecosystems by single-cell sequencing: promises and limitations. Genome Biol. 2018; 19(1):211. PMC: 6276232. DOI: 10.1186/s13059-018-1593-z. View

Jiao X, Wei X, Li S, Liu C, Chen H, Gong J . A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer. NPJ Precis Oncol. 2021; 5(1):36. PMC: 8096820. DOI: 10.1038/s41698-021-00172-5. View

Joanito I, Wirapati P, Zhao N, Nawaz Z, Yeo G, Lee F . Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet. 2022; 54(7):963-975. PMC: 9279158. DOI: 10.1038/s41588-022-01100-4. View

Puram S, Tirosh I, Parikh A, Patel A, Yizhak K, Gillespie S . Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017; 171(7):1611-1624.e24. PMC: 5878932. DOI: 10.1016/j.cell.2017.10.044. View

10.

Hause R, Pritchard C, Shendure J, Salipante S . Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016; 22(11):1342-1350. DOI: 10.1038/nm.4191. View

11.

Yildiz A, Kaya Y, Tanriverdi O . Effect of the Interaction Between Selenium and Zinc on DNA Repair in Association With Cancer Prevention. J Cancer Prev. 2019; 24(3):146-154. PMC: 6786808. DOI: 10.15430/JCP.2019.24.3.146. View

12.

Willis J, Lefterova M, Artyomenko A, Kasi P, Nakamura Y, Mody K . Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel. Clin Cancer Res. 2019; 25(23):7035-7045. DOI: 10.1158/1078-0432.CCR-19-1324. View

13.

Bachmann M, Gallimore A, Linkert S, Cerundolo V, Lanzavecchia A, Kopf M . Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J Exp Med. 1999; 189(10):1521-30. PMC: 2193636. DOI: 10.1084/jem.189.10.1521. View

14.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

15.

Vitale I, Sistigu A, Manic G, Rudqvist N, Trajanoski Z, Galluzzi L . Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends Cell Biol. 2019; 29(5):396-416. DOI: 10.1016/j.tcb.2019.01.003. View

16.

Lu Z, Chen H, Jiao X, Zhou W, Han W, Li S . Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier. J Immunother Cancer. 2020; 8(2). PMC: 7430448. DOI: 10.1136/jitc-2020-000631. View

17.

Kautto E, Bonneville R, Miya J, Yu L, Krook M, Reeser J . Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget. 2016; 8(5):7452-7463. PMC: 5352334. DOI: 10.18632/oncotarget.13918. View

18.

Trabucco S, Gowen K, Maund S, Sanford E, Fabrizio D, Hall M . A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples. J Mol Diagn. 2019; 21(6):1053-1066. PMC: 7807551. DOI: 10.1016/j.jmoldx.2019.06.011. View

19.

Yi M, Niu M, Xu L, Luo S, Wu K . Regulation of PD-L1 expression in the tumor microenvironment. J Hematol Oncol. 2021; 14(1):10. PMC: 7792099. DOI: 10.1186/s13045-020-01027-5. View

20.

Scrucca L, Fop M, Murphy T, Raftery A . mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models. R J. 2016; 8(1):289-317. PMC: 5096736. View